ALIMERA SCIENCES INC
Profile
Company Names
ALIMERA SCIENCES INC
Addresses
6310 TOWN SQUARE, SUITE 400, ALPHARETTA, GA 30005
6120 WINDWARD PARKWAY, STE 290, ALPHARETTA, GA 30005
Phone Numbers
(678) 990-5740
6789905740
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$173,832,486.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-03-24
$81,000,000.00
$81,000,000.00
$0.00
Equity
5
2021-04-14
$10,000,000.00
$10,000,000.00
$0.00
Equity
4
2014-01-31
$37,500,000.00
$37,500,000.00
$0.00
Equity
3
2012-10-02
$40,000,000.00
$40,000,000.00
$0.00
Equity
2
2011-05-16
$332,486.00
$332,486.00
$0.00
1
2009-08-25
$5,000,000.00
$5,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK
BROOKS
DIRECTOR
BRIAN
HALAK
DIRECTOR
OCEANA THERAPEUTICS, INC.
| ALIMERA SCIENCES INC
| ORAYA THERAPEUTICS INC
| CORTRIA CORP
| GI DYNAMICS, INC.
| TOBIRA THERAPEUTICS, INC.
| CORRIDOR PHARMACEUTICALS, INC.
| KONA MEDICAL, INC.
| NANOTHERA CORP
| BIONANOMATRIX INC
| BIONANO GENOMICS, INC
| WINDMIL THERAPEUTICS, INC.
| SONOTHERA, INC.
| THIRDLAW MOLECULAR, INC.
BRIAN
K.
HALAK
DIRECTOR
ANDERS
HOVE
DIRECTOR
GARHENG
KONG
DIRECTOR
CEMPRA HOLDINGS, LLC
| APPLIED GENETIC TECHNOLOGIES CORP
| VIAMET PHARMACEUTICALS INC
| ALDAGEN INC
| TRANSENTERIX INC
| CANCERGUIDE DIAGNOSTICS, INC.
| SARCODE BIOSCIENCE INC.
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| HISTOGENICS CORP
| CEMPRA, INC.
| ALIMERA SCIENCES INC
| FIRST AID BEVERAGES, INC.
| SOFINNOVA HEALTHQUEST PARTNERS, L.P.
| TRICE MEDICAL, INC.
| LONGWOOD OPPORTUNITY OFFSHORE FUND, LTD
| LONGWOOD OFFSHORE, LTD.
| CASTLE BIOSCIENCES INC
| STRONGBRIDGE BIOPHARMA PLC
| ACUTA OPPORTUNITY OFFSHORE FUND, LTD.
| ACUTA CAPITAL OFFSHORE FUND, LTD.
| HEALTHQUEST PARTNERS II, L.P.
| MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| VENUS CONCEPT LTD.
| ALCRESTA THERAPEUTICS, INC.
| MELINTA THERAPEUTICS, INC. /NEW/
| AVEDRO INC
| CLEANSLATE CENTERS, INC.
| BARDY DIAGNOSTICS, INC.
| HEALTHQUEST PARTNERS III, L.P.
| HEALTHQUEST AJAX II SPV, L.P.
| AJAX HEALTH II LLC
| VENUS CONCEPT INC.
| HEALTHQUEST AJAX III SPV, L.P.
| AJAX HEALTH III LLC
| HEALTHQUEST AJAX III-A SPV, L.P.
| HEALTHQUEST MADISON SPV, L.P.
| HEALTHQUEST PARTNERS IV, L.P.
| HEALTHQUEST TACTICAL OPPORTUNITIES FUND, L.P.
| HOME HOSPITAL NEWCO, INC.
| HQTOF ENDEAVOR SPV, L.P.
| HQTOF ENDEAVOR SPV-B, L.P.
| NOMAD HEALTH, INC.
C.
DANIEL
MYERS
EXECUTIVE OFFICER, DIRECTOR
RUSSELL
SKIBSTED
EXECUTIVE OFFICER
MARY
T.
SZELA
DIRECTOR
BRYCE
YOUNGREN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2023-03-24
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2023-03-24
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2021-04-14
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-01-31
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-10-02
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2009-08-25

